Random42 is the global market leader in the provision of medical animation and digital media services to the healthcare and pharmaceutical industry. Its core capabilities include 2D and 3D animation, virtual and augmented reality experiences, interactive services, mobile applications and website design.
Random42 combines scientific knowledge with high quality animation providing bespoke products to suit each individual clients’ requirements. Led by an experienced management group, the wider Random42 team comprises PhD scientists, and a high proportion of graduates with first and/or second degrees in scientific disciplines and illustration/graphic design. The company’s products and services are typically used by its clients to explain the underlying science during the drug discovery and launch process, and for corporate communication and education purposes.
Based in London and employing 50 people, Random42 has client relationships across Europe, USA, and Asia and has worked directly with 22 of the top 25 pharmaceutical companies worldwide. It has won over 150 industry awards during its 25 year history.
Since acquiring the business in March 2015, Vespa Capital has supported Random42 in developing its financial team and systems, undertaken substantial investment in infrastructure including premises and people, introduced new business leads, and encouraged the marketing team to actively pursue opportunities in the biotechnology and medical devices sectors.
Ben Ramsbottom, CEO, Random42
"Vespa Capital have been very supportive partners and have encouraged us to make significant investment during the last 2½ years. We are grateful for all their help and guidance and thank them for their support.”
Nigel Hammond, Managing Partner, Vespa Capital
"Random42 has been one of the most interesting investments we have been privileged to be involved with and we have enjoyed our time together. We are confident that Random42 has a bright future and look forward to keeping in touch”